Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS

The COVID-19 pandemic caused by the novel SARS-CoV-2 is more contagious than other coronaviruses and has higher rates of mortality than influenza. As no vaccine or drugs are currently approved to specifically treat COVID-19, identification of effective therapeutics is crucial to treat the afflicted...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Res Sq
Main Authors: O’Donovan, Sinead M, Eby, Hunter, Henkel, Nicholas D, Creeden, Justin, Imami, Ali, Asah, Sophie, Zhang, Xiaolu, Wu, Xiaojun, Alnafisah, Rawan, Taylor, R. Travis, Reigle, James, Thorman, Alexander, Shamsaei, Behrouz, Meller, Jarek, McCullumsmith, Robert E
פורמט: Artigo
שפה:Inglês
יצא לאור: American Journal Experts 2020
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7336712/
https://ncbi.nlm.nih.gov/pubmed/32702077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21203/rs.3.rs-25643/v1
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים